// App-Quantinova.ai

9564 : Immune checkpoint inhibition (ICI) in advanced cutaneous squamous cell carcinoma (cSCC): Clinical response and correlative biomarker analysis.

Researchers

Presenter

  • Jong Chul Park

Principal Investigators

  • Lori J. Wirth

  • Keith Flaherty

  • Donald P. Lawrence

  • Shadmehr Demehri

  • Stefan Kraft

  • Ruth Foreman

  • John R Clark

  • Justine Vanessa Cohen

  • Yuhree Kim

  • Genevieve Marie Boland

  • Dennie Tompers Frederick

  • Ryan J. Sullivan

Medical Centers

  • Massachusetts General Hospital Cancer Center, Boston, MA

  • Massachusetts General Hospital, Boston, MA

  • Massachusetts General Hospital/Dana-Farber Cancer Institute, Boston, MA

  • Center for Dermatopathology, Freiburg, Germany

Locations

  • United States

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • Pembrolizumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved